Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02401022 · ClinicalTrials.gov registry record · Phase 2
The Study of AZD8529 for Smoking Cessation in Female Smokers
A Phase 2 study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 2
- Development phase
- 214
- Enrollment target
NCT02401022: Completed Phase 2 study, sponsored by National Institute on Drug Abuse (NIDA).
NCT02401022 is a Phase 2 study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 214 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (61% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02401022, a Phase 2 study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 214 participants
- Enrollment target
Study Summary
To evaluate the efficacy and safety of AZD8529 for smoking cessation in female smokers.
Primary Outcome
The number of subjects in each treatment group who are smoking abstinence during the last 4 weeks of the treatment phase (weeks 10 through 13)
Interventions
- DRUG AZD8529
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 214 participants |
| Start Date | 2015-07 |
| Est. Completion | 2017-01 |
| Phase | Phase 2 |
What the finished NCT02401022 record still lists
NCT02401022 is an interventional study that assigns participants to a tested intervention. The registered 214 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (61% higher).
The record links to 0 conditions, and to 1 intervention - of which AZD8529 is the first listed.
NCT02401022 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02401022 about?
NCT02401022 is a clinical study titled "The Study of AZD8529 for Smoking Cessation in Female Smokers". To evaluate the efficacy and safety of AZD8529 for smoking cessation in female smokers.
What is the current status of trial NCT02401022?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 214 participants. The study started on 2015-07. Estimated completion is 2017-01.
What interventions are being tested in trial NCT02401022?
The interventions under investigation include: AZD8529 (DRUG).
Who is sponsoring clinical trial NCT02401022?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02401022's enrollment target sits among peer trials
214 290th of 2000 higher than 1,711 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04030507 · 214 participants · NA
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
- NCT04421248 · 214 participants · Phase 4
Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder
- NCT04667520 · 214 participants · NA
Testing a Lifestyle Physical Activity Intervention for Women With Depression in Alcohol Treatment
- NCT05418868 · 214 participants · Phase 1
A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia